ABSTRACT
BACKGROUND Asthma is recognized as an inflammatory disease of the airways, but inflammation may also affect the parenchyma and pulmonary vasculature. Hyperpolarized 129Xe MRI and MR spectroscopy (MRS) provide a way to quantify the transfer of gas from the airways through the alveolar membrane and its binding to hemoglobin in the red blood cells (RBC) of the pulmonary microvasculature. The vast majority of 129Xe MRS studies have investigated interstitial lung disease and the ratio of 129Xe binding to the RBC and 129Xe present in the alveolar membrane, (RBC:membrane) which is a surrogate of oxygen gas-transfer to the blood. We wondered if 129Xe RBC:membrane would differ in asthma patients as compared to healthy volunteers because of recent work showing abnormally diminished pulmonary vascular small-vessel structure in severe-asthma.
RESEARCH QUESTION Do 129Xe MRI gas-transfer measurements differ significantly in patients with moderate-severe asthma?
STUDY DESIGN AND METHODS In this retrospective study, healthy (NCT02484885) and asthma (NCT04651777; NCT02351141) participants were evaluated who provided written informed consent.
RESULTS Thirty-one participants with asthma (mean age=55 years ±18; 22 females) and 32 healthy volunteers (mean age=31 years ±14; 12 females) with 129Xe MRS were evaluated. FEV1, VDP and DLCO/KCO were significantly different in asthma compared to healthy participants. Age-corrected 1RBC:membrane was significantly different in moderate-severe asthma (0.32±0.09) as compared to healthy participants (0.47±0.12, P=.01). RBC:membrane was significantly related to pulse-oximetry hemoglobin estimates (ρ=.29; P=.04) and DLCO (ρ=.71; P<.001). Significant relationships between 129Xe RBC:membrane and age were observed in healthy (ρ=-.55; P=.002) and asthma participants (ρ=-0.49; P=.006), adjusted for sex. A significant ANCOVA model also revealed the influence of age (P=.002), sex (P<.001), hemoglobin (P=.003) and asthma status (P=.02) on RBC:membrane.
INTERPRETATION 129Xe RBC:membrane values were significantly different in moderate-severe asthma compared to healthy volunteers and were explained by age, sex, hemoglobin, and asthma status.
Competing Interest Statement
Grace Parraga PhD FCAHS: Dr Parraga reports speaking honoraria (GSK; Polarean)
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was conducted with institutional affiliations to the University of Western Ontario and Robarts Research Institute. Ethical approval was granted by the Health Sciences Research Ethics Board at the University of Western Ontario, and the study is registered with ClinicalTrials.gov under the identifiers NCT02484885, NCT04651777, and NCT02351141.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Summary of Conflict of Interest Statements: Sam Tcherner BSc: No conflicts of interest.
Ali Mozaffaripour BMSc: No conflicts of interest.
Alexander M Matheson PhD: No conflicts of interest.
Alexander Biancaniello MSc: No conflicts of interest.
Cory Yamashita MD FRCPC: No conflicts of interest.
Grace Parraga PhD FCAHS: Dr Parraga reports speaking honoraria (GSK; Polarean)
Data Availability
All data produced in the present work are contained in the manuscript.
